Regenxbio Inc Cash Flow-to-Debt Ratio
Regenxbio Inc cash flow-to-debt ratio. Regenxbio Inc (RGNX) has a Cash Flow-to-Debt Ratio of -0.20x as of June 2026, meaning its operating cash flow of $-62.24 Million could theoretically repay 0% of its total liabilities ($314.85 Million) in one year. Check RGNX cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Regenxbio Inc (2013–2025)
Cash flow-to-debt ratio of Regenxbio Inc from 2013 to 2025. Historical debt coverage capacity for Regenxbio Inc across 13 annual periods. Check Regenxbio Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Regenxbio Inc Cash Flow-to-Debt Ratio by Year (2013–2025)
Regenxbio Inc cash flow-to-debt ratio by year from 2013 to 2025. Year-by-year debt coverage analysis for Regenxbio Inc. For the full cash flow conversion analysis, see how efficiently does Regenxbio Inc generate cash.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.35x | $-123.96 Million | $350.30 Million | ▲ +57.8% |
| 2024 | -0.84x | $-173.12 Million | $206.34 Million | ▼ -0.7% |
| 2023 | -0.83x | $-218.41 Million | $262.23 Million | ▼ -27.3% |
| 2022 | -0.65x | $-207.49 Million | $317.07 Million | ▼ -204.5% |
| 2021 | 0.63x | $218.88 Million | $349.61 Million | ▲ +482.6% |
| 2020 | -0.16x | $-54.06 Million | $330.41 Million | ▲ +92.8% |
| 2019 | -2.26x | $-107.70 Million | $47.71 Million | ▼ -175.4% |
| 2018 | 2.99x | $104.65 Million | $34.97 Million | ▲ +180.8% |
| 2017 | -3.71x | $-57.99 Million | $15.65 Million | ▲ +16.1% |
| 2016 | -4.42x | $-48.56 Million | $10.99 Million | ▲ +10.3% |
| 2015 | -4.92x | $-22.52 Million | $4.57 Million | ▼ -1786.3% |
| 2014 | -0.26x | $-2.40 Million | $9.19 Million | ▲ +59.7% |
| 2013 | -0.65x | $-3.01 Million | $4.65 Million | — |